Status:

NOT_YET_RECRUITING

Study of CM512 Injection in Subjects With Chronic Spontaneous Urticaria(CSU)

Lead Sponsor:

Keymed Biosciences Co.Ltd

Conditions:

Chronic Spontaneous Urticaria (CSU)

Eligibility:

All Genders

18-75 years

Phase:

PHASE2

Brief Summary

This study is a multicenter, randomized, double-blind, placebo-controlled phase II clinical study to evaluate the efficacy, safety, pharmacokinetics, pharmacodynamics, and immunogenicity of CM512 in s...

Eligibility Criteria

Inclusion

  • Voluntarily sign the Informed Consent Form.
  • Age ≥ 18 years old and ≤ 75 years old.
  • Patients with a diagnosis of CSU before screening visit, and the duration was ≥6 months.
  • Pruritus and wheals existed for more than 6 weeks before screening, despite regular H1-Antihistamines(AH) treatment during this period.
  • A stable dose of the second-generation H1-Antihistamines(AH) has been continuously used for at least 3 days before screening, and the individual is willing to continue to use it stably as stipulated in the protocol during the study period.
  • Within 7 days before randomization, UAS7≥16 and ISS7 ≥8.

Exclusion

  • Not enough washing-out period for previous therapy.
  • Planned major surgical procedure during the patient's participation in this study.
  • Has ever experienced a systemic allergic reaction or immediate allergic reaction to any biological product (including any excipients).
  • CM512 has been used before.
  • Women who are pregnant or breastfeeding. During the study period, subjects who had plans to have children, or did not agree to contraception.
  • With any medical or non-medical conditions that are not suitable for participation in this study by investigators.

Key Trial Info

Start Date :

September 15 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

January 14 2027

Estimated Enrollment :

48 Patients enrolled

Trial Details

Trial ID

NCT07166211

Start Date

September 15 2025

End Date

January 14 2027

Last Update

September 16 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Tianjin Academy of Traditional Chinese Medicine Affiliate Hospital

Tianjin, Tianjin Municipality, China